세계의 심혈관 정보 시스템 시장 규모, 점유율, 산업 동향 분석 리포트 : 유형별, 동작 모드별, 지역별 전망과 예측(2023-2030년)
Global Cardiovascular Information System Market Size, Share & Industry Trends Analysis Report By Type (CVIS, and CPACS), By Mode Of Operation (Web-based, Cloud-based, and On-site), By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1384662
리서치사 : KBV Research
발행일 : 2023년 10월
페이지 정보 : 영문 207 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ₩ 5,197,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ₩ 6,237,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ₩ 8,732,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

심혈관 정보 시스템 시장 규모는 2030년까지 22억 달러에 달할 것으로 예측되며, 예측 기간 중 CAGR은 10.2%의 시장 성장률로 상승합니다.

KBV Cardinal matrix에 게재된 분석에 따르면 Cisco Systems, Inc.와 Oracle Corporation이 이 시장에서 선구자입니다. 2021년 7월, Cisco Systems, Inc.는 Socio Labs, Inc.의 인수를 발표, Cisco Webex의 플랫폼 제공을 강화하고, 온라인 이벤트에서 더 나은 체험을 고객에게 제공합니다. Honeywell International, Inc., McKesson Corporation, Siemens Healthineers AG 등의 기업은 이 시장의 주요 이노베이터입니다.

COVID-19의 영향 분석

의료시설은 전염병으로 인한 재정적 제약에 직면했습니다. 많은 자원이 COVID-19 대응에 투입되어 다른 의료 기술에 대한 자금 배분에 영향을 미쳤습니다. 그 결과, 일부 의료 서비스 프로바이더는 CVIS 및 기타 긴급하지 않은 시스템에 대한 투자를 연기했습니다. 전염병은 의료 시설의 정상적인 운영을 방해했습니다. 이로 인해 CVIS를 포함한 신기술 도입이 지연되었습니다. 따라서 전염병은 시장에 비교적 긍정적인 영향을 미쳤으며, CVIS의 채택은 의료 분야에서 중요한 요소가 되어 향후 수년간 시장의 긍정적인 성장으로 이어질 것입니다.

시장 성장 요인

효율성 향상 및 워크플로우 최적화

헬스케어의 효율성이 강조되면서 임상 워크플로우를 간소화하고, 관리 부담을 줄이며, 환자 치료의 전반적인 효율성을 높이는 CVIS 시스템 도입이 증가하고 있습니다. 시장에서는 데이터 검색, 검사 해석, 보고서 작성과 관련된 다양한 작업을 자동화하는 전문 솔루션을 제공함으로써 이러한 수요에 부응하고 있습니다. 이러한 최적화는 신속한 진단과 치료를 가능하게 하여 환자 결과에 직접적인 영향을 미치고, 결과적으로 의료진과 환자 모두에게 더 나은 임상 효과와 만족도를 가져다줍니다. 데이터베이스 의료는 방대한 양의 환자 데이터와 진단 정보를 효율적으로 수집, 저장, 관리할 수 있는 고급 CVIS 솔루션에 대한 수요를 촉진하고 있습니다. 따라서 효율적인 데이터 관리와 워크플로우 최적화를 가능하게 하는 CVIS 솔루션에 대한 수요 증가는 이러한 시스템이 현대 의료 서비스 제공에 있으며, 매우 중요한 역할을 하고 있음을 보여줍니다.

헬스케어 인프라 확대

급격한 인구 증가, 특히 도시 지역에서는 의료 인프라에 대한 수요가 증가하고 있습니다. 늘어나는 의료 수요에 대응하기 위해서는 시설과 서비스를 확충해야 합니다. 세계 인구의 고령화로 인해 고령화 관련 건강 문제를 해결하고 장기적인 치료를 제공하는 의료 서비스의 필요성이 증가하고 있습니다. 의료 인프라의 확장은 종종 순환기내과나 순환기 치료 시설의 신설을 포함하며, CVIS 솔루션은 이러한 진료과에서 환자 데이터와 진단 정보를 효율적으로 관리할 수 있는 종합적인 플랫폼을 제공하는 데 도움을 주고 있습니다. 의료 인프라의 확장은 심혈관 환자 데이터와 진단 정보의 효율적인 관리를 지원하는 전문 솔루션에 대한 수요를 창출하여 시장의 성장과 중요성을 강화하고 있습니다.

시장 성장 억제요인

높은 도입 비용 및 복잡성

CVIS와 관련된 높은 도입 비용은 많은 의료 시설에 큰 장애물이 되고 있습니다. 이러한 비용에는 하드웨어 및 소프트웨어 구매, 커스터마이징, 기존 시스템과의 통합, 종합적인 직원 교육에 대한 비용이 포함됩니다. 소규모 의료 기관이나 한정된 예산으로 운영되는 의료기관의 경우, 이러한 재정적 요구사항이 너무 커서 CVIS를 도입하는 데 어려움을 겪을 수 있습니다. 그 결과, 많은 의료 서비스 프로바이더들은 CVIS가 제공하는 고급 데이터 관리 및 진단 기능을 이용할 수 없어 의료 서비스의 디지털 격차를 초래하고 있습니다. 이러한 문제는 시장 확대에 걸림돌이 되고 있으며, 데이터 관리 간소화, 진단 역량 강화, 환자 치료 개선 등 CVIS가 제공할 수 있는 잠재적 이점을 제한하고 있습니다.

유형별 전망

유형별로 시장은 CVIS와 CPACS로 분류되며, CPACS 부문은 2022년 시장에서 큰 매출 점유율을 기록했습니다. 심혈관 이미지 저장 통신 시스템(CPACS)은 심 초음파, 혈관조영술, 핵의학 스캔과 같은 심혈관 이미지를 관리하도록 설계되었으며, CPACS는 이러한 이미지의 안전한 저장소를 제공하여 의료 전문가가 쉽게 액세스 할 수 있도록합니다. 포맷, 해상도, 압축 등 정확한 진단과 치료 계획에 필수적인 심혈관 영상의 품질과 일관성을 보장합니다.

운영 모드 전망

운영 모드에 따라 시장은 웹 기반, 클라우드 기반, 현장으로 구분됩니다. 웹 기반 부문은 2022년 시장에서 가장 높은 매출 점유율을 차지했습니다. 웹 기반 CVIS는 웹 브라우저를 통해 인터넷로 연결된 모든 기기에서 액세스할 수 있습니다. 이러한 유연성은 의료 전문가가 다양한 위치에서 환자 데이터와 진단 정보를 얻을 수 있도록 하여 원격 액세스 및 원격의료를 촉진합니다. 웹 기반 CVIS는 대규모 현장 인프라나 하드웨어를 필요로 하지 않기 때문에 초기 도입 비용을 낮출 수 있습니다. 따라서 특히 소규모 의료기관의 경우 비용 효율성이 높습니다.

지역별 전망

지역별로 보면 시장은 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다. 북미 부문은 2022년 이 시장에서 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 국립 의학 도서관에 따르면 경제 발전, 문화적 관습, 유전적 소인, 치료법 및 위험 요인에 대한 동향의 차이가 북미 전역의 심부전 발생률의 변동에 기여하고 있습니다. 미국과 캐나다는 지역적 특성, 경제 및 인프라 시스템, 문화적 전통이 유사한 선진국입니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장의 개요

제3장 시장 개요

제4장 경쟁 분석 - 세계

제5장 세계의 심혈관 정보 시스템 시장 : 유형별

제6장 세계의 심혈관 정보 시스템 시장 : 동작 모드별

제7장 세계의 심혈관 정보 시스템 시장 : 지역별

제8장 기업 개요

제9장 시장의 성공 필수 조건

KSA
영문 목차

영문목차

The Global Cardiovascular Information System Market size is expected to reach $2.2 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.

Over the forecast period, it is anticipated that the presence of quickly developing economies like China and India, where the healthcare system is rapidly improving, will accelerate the region's development. Thus, the Asia Pacific region would generate 25% share of the market by 2030. Due to a sharp rise in the number of patients, the region has seen a significant increase in healthcare spending, which has increased investments in R&D activities pertaining to cardiovascular diseases. Due to the development of novel and cutting-edge goods and technologies, the regional market has grown faster.

The major strategies followed by the market participants are Acquisitions as the key developmental strategy to keep pace with the changing demands of end users. For instance, In September, 2022, McKesson Corporation announced the acquisition of Rx Savings Solutions, to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements. Additionally, Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, to further build out its Learning Health Network consortium.

Based on the Analysis presented in the KBV Cardinal matrix; Cisco Systems, Inc. and Oracle Corporation are the forerunners in the Market. In July, 2021, Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., to enhance Cisco Webex's platform offerings and would provide customers with a better experience in online events. Companies such as Honeywell International, Inc., McKesson Corporation, Siemens Healthineers AG are some of the key innovators in the Market.

COVID-19 Impact Analysis

Healthcare facilities faced financial constraints due to the pandemic. Many resources were diverted to address COVID-19, impacting the allocation of funds for other healthcare technologies. As a result, some healthcare providers deferred investments in CVIS or other non-urgent systems. The pandemic disrupted regular operations in healthcare facilities. This led to delays in the implementation of new technologies, including CVIS. Therefore, the pandemic had a comparatively positive impact on the market. The adoption of CVIS has become a key component in healthcare, leading to positive growth in the market in the coming years.

Market Growth Factors

Increased efficiency and workflow optimization

The emphasis on efficiency in healthcare has led to the adoption of CVIS systems that streamline clinical workflows, reducing administrative burdens and enhancing the overall efficiency of patient care. The market has responded to this demand by providing specialized solutions that automate various tasks related to data retrieval, test interpretation, and report generation. This optimization directly impacts patient outcomes, as it enables quicker diagnosis and treatment, resulting in improved clinical efficacy and satisfaction for healthcare providers and patients alike. Data-driven medicine has fueled the demand for advanced CVIS solutions that can efficiently capture, store, and manage vast amounts of patient data and diagnostic information. Therefore, the increasing demand for CVIS solutions that enable efficient data management and workflow optimization underscores these systems' pivotal role in modern healthcare delivery.

Expansion of healthcare infrastructure

Rapid population growth, particularly in urban areas, increases healthcare infrastructure demands. In order to accommodate the increasing number of patients looking for medical care, facilities, and services must be expanded. As the global population ages, there is a greater need for healthcare services to address age-related health issues and provide long-term care. Expanding healthcare infrastructure often includes establishing new cardiology departments and cardiovascular care facilities. CVIS solutions are instrumental in providing a comprehensive platform for managing patient data and diagnostic information efficiently within these departments. The expansion of healthcare infrastructure has bolstered the growth and significance of the market by creating a demand for specialized solutions that support the efficient management of cardiovascular patient data and diagnostic information.

Market Restraining Factors

High implementation costs and complexity

The high implementation costs associated with CVIS present a major hindrance to many healthcare facilities. These costs encompass the purchase of hardware and software and expenses related to customization, integration with existing systems, and comprehensive staff training. For smaller healthcare organizations or those operating with limited budgets, these financial requirements can be prohibitive, discouraging the adoption of CVIS. As a result, many healthcare providers are unable to access the advanced data management and diagnostic capabilities offered by CVIS, leading to a digital divide in healthcare services. These challenges hinder the expansion of the market, limiting the potential benefits these systems can offer in terms of streamlined data management, enhanced diagnostic capabilities, and improved patient care.

Type Outlook

On the basis of type, the market is classified into CVIS and CPACS. The CPACS segment recorded a significant revenue share in the market in 2022. The cardiovascular picture archiving and communication system (CPACS) is designed to manage cardiovascular images, including echocardiograms, angiograms, and nuclear medicine scans. It provides a secure repository for these images, making them readily accessible to healthcare professionals. CPACS ensures the quality and consistency of cardiovascular images, including image format, resolution, and compression, which is critical for accurate diagnosis and treatment planning.

Mode Of Operation Outlook

Based on mode of operation, the market is characterized into web-based, cloud-based, and on-site. The web-based segment garnered the highest revenue share in the market in 2022. Web-based CVIS is accessible from any internet-connected device with a web browser. This flexibility allows healthcare professionals to retrieve patient data and diagnostic information from different locations, promoting remote access and telemedicine. The initial costs of implementing web-based CVIS can be lower because it doesn't require extensive on-site infrastructure and hardware. This can make it more cost-effective, particularly for smaller healthcare institutions.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the market in 2022. According to the National Library of Medicine, differences in economic development, cultural practices, genetic predisposition, and trends in treatments and risk factors contribute to variations in heart failure rates across North America. The US and Canada are industrialized countries with similar geographic characteristics, economic and infrastructure systems, and cultural traditions.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Cisco Systems, Inc., Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), Lumedx Corporation (Intelerad Medical Systems Incorporated), Agfa-Gevaert Group, Honeywell International, Inc., and McKesson Corporation

Strategies Deployed in Cardiovascular Information System Market

Mergers & Acquisition:

Feb-2023: GE HealthCare Technologies, Inc. signed an agreement to acquire Caption Health, Inc., a healthcare technology company specializing in artificial intelligence-driven ultrasound guidance to improve the quality and accessibility of medical imaging. Through this acquisition, GE HealthCare would be focused on performing fundamental echocardiogram assessments and making it possible to identify early signs of conditions such as heart failure in high-risk individuals.

Sep-2022: McKesson Corporation announced the acquisition of Rx Savings Solutions (RxSS), a healthcare technology company specializing in innovative prescription drug cost-saving solutions for both consumers and employers. Through this partnership, McKesson Corporation would be able to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements.

Jul-2021: Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., an American event management platform provider. The acquisition enhances Cisco Webex's platform offerings and would provide customers with a better experience in online events.

Apr-2021: Siemens Healthineers AG acquired Varian Medical Systems, Inc., a global leader in cancer treatment solutions, providing advanced radiotherapy, radiosurgery, and brachytherapy technologies to improve the lives of cancer patients. Through this partnership, Siemens aimed to tackle the rising demand for personalized, data-informed diagnostics and precise cancer treatment, equipping us to combat the escalating global cancer epidemic.

Apr-2021: Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science industry, a division of Kantar Group. Through this acquisition, Cerner aimed to further build out its Learning Health Network consortium.

Feb-2021: Koninklijke Philips N.V. acquired BioTelemetry, Inc., a company that provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Through this acquisition, Philips would be able to provide their clients with healthcare solutions with a primary focus on cardiac patients and other medical conditions, both within the hospital and in the comfort of their homes.

Aug-2020: Koninklijke Philips N.V. took over Intact Vascular, Inc., a medical device company focused on developing innovative solutions for the treatment of peripheral artery disease. Through this acquisition, Philips would be able to offer more solutions for Peripheral Artery Disease.

Product Launches:

Feb-2023: Honeywell International, Inc. introduced Spectra MG BIO fibers, a bio-based variation of Spectra fibres, known for their exceptional strength, durability, and lightweight properties, used in various applications including ballistic protection and industrial use.

Partnerships, Collaborations & Agreements:

Jul-2023: GE HealthCare Technologies, Inc., came into partnership with Elekta, a leader in radiation therapy, in the Indian market. Through this partnership, GE HealthCare would aim to facilitate greater efficiency, precision, and personalization throughout the entire cancer care journey, emphasizing our commitment to investing in solutions that enhance the quality of cancer care while making it more patient cantered.

Oct-2022: GE Healthcare came into collaboration, both companies would advance their efforts to streamline the oncology care process, focusing on enhanced data handling, pathology digitization, and simplified data retrieval.

Oct-2022: Siemens Healthineers AG came into partnership with iMedrix Systems Pvt Ltd., a healthcare technology company specializing in remote patient monitoring solutions and telemedicine services. Through this partnership, both companies would provide telecardiology technology to help their clients generate deeper insights into health.

Sep-2022: McKesson Corporation partnered with CVS Health, a diversified healthcare company that operates pharmacies, healthcare clinics, and health insurance services, focusing on improving access to quality healthcare and pharmaceuticals. Through this partnership, both companies would be able to fulfil the growing customer demands.

Jul-2020: Cerner Corporation, a subsidiary of Oracle Corporation came into partnership with Holon Solutions, a healthcare technology company focused on data integration and interoperability solutions to improve healthcare delivery and patient outcomes. Through this partnership, Cerner accelerated the development of, seamless clinical decision support at the point of care.

Oct-2019: LUMEDX, a subsidiary of Intelerad Medical Systems Incorporated, came into partnership with MedAxiom, a US-Based Business Consulting and Services company. Through this partnership, LUMEDX would aim to accelerate the enhancement of the HealthView Analytics (HVA) platform to provide better patient outcomes and significant cost savings.

Scope of the Study

Market Segments covered in the Report:

By Type

By Mode Of Operation

By Geography

Companies Profiled

Unique Offerings from KBV Research

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market At a Glance

Chapter 3. Market Overview

Chapter 4. Competition Analysis - Global

Chapter 5. Global Cardiovascular Information System Market, by Type

Chapter 6. Global Cardiovascular Information System Market, by Mode Of Operation

Chapter 7. Global Cardiovascular Information System Market, by Region

Chapter 8. Company Profiles

Chapter 9. Winning Imperative for Cardiovascular Information System Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기